Status:
COMPLETED
Placental Volume, Flow, and Vascularity Study
Lead Sponsor:
University of Minnesota
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-45 years
Brief Summary
The purpose of this preliminary study is to implement an automated and standardized computer-based method that accurately measures placental volume, blood flow, and vascularity. This will be accomplis...
Detailed Description
Preeclampsia is defined as a multi-system disorder typically characterized by hypertension, proteinuria, and/or end organ damage. Preeclampsia can develop rapidly at any time after 20 weeks gestation ...
Eligibility Criteria
Inclusion
- Singleton gestation
- Qualify for a first-trimester screen at the time of enrollment. Criteria for the screen include pregnancy with gestational age between 10 weeks 3 days and 13 weeks 6 days of gestation as well as a crown-rump length between 40 and 84 mm.
- Complete a first-trimester ultrasound at the qualifying M Health Fairview Maternal Fetal Medicine Clinics, which include University Riverside, Ridges, South Dale, and Health East sites
- Provide a blood sample for either completion of the first-trimester screen and/or for the completion of the research study
Exclusion
- Multi-fetal gestation or pregnancy with major fetal congenital anomalies and/or known fetal aneuploidy
- Unwilling to complete a first-trimester ultrasound and/or unwilling to provide a serum sample
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT04900207
Start Date
March 10 2021
End Date
June 30 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455